Published in Ann Rheum Dis on April 01, 1982
Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev (2010) 4.48
Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis. Ann Rheum Dis (1989) 1.71
Transin/stromelysin expression in rheumatoid synovium. A transformation-associated metalloproteinase secreted by phenotypically invasive synoviocytes. Am J Pathol (1989) 1.50
Localisation of lysozyme mRNA in rheumatoid synovial membrane by in situ hybridisation. Ann Rheum Dis (1989) 1.40
Features of synovial membrane identified with monoclonal antibodies. Clin Exp Immunol (1985) 1.25
Localisation of apoptosis and expression of apoptosis related proteins in the synovium of patients with rheumatoid arthritis. Ann Rheum Dis (1996) 1.14
The nature and origins of synovium: experimental approaches to the study of synoviocyte differentiation. J Anat (1994) 1.14
Immunocytochemical analysis of human synovial lining cells: phenotypic relation to other marrow derived cells. Ann Rheum Dis (1991) 1.08
Synovial lining cell hyperplasia in rheumatoid arthritis: dogma and fact. Ann Rheum Dis (1988) 0.98
Localisation of vitronectin receptor immunoreactivity and tartrate resistant acid phosphatase activity in synovium from patients with inflammatory or degenerative arthritis. Ann Rheum Dis (1993) 0.95
Immunohistology of rheumatoid nodules and rheumatoid synovium. Ann Rheum Dis (1988) 0.94
Expression of integrin family of cell adhesion receptors in rheumatoid synovium. Alpha 6 integrin subunit in normal and hyperplastic synovial lining cell layer. Am J Pathol (1993) 0.94
Expression of chemokines CXCL4 and CXCL7 by synovial macrophages defines an early stage of rheumatoid arthritis. Ann Rheum Dis (2015) 0.91
Ultrastructural localisation of muramidase in the human synovial membrane. Ann Rheum Dis (1987) 0.91
Human epidermal growth factor for the stratification of synovial lining layer and neovascularisation in rheumatoid arthritis. Ann Rheum Dis (1989) 0.91
Synovial macrophages. Ann Rheum Dis (1995) 0.90
Synovial membrane cellularity and vascularity. Ann Rheum Dis (1995) 0.82
Differential binding of chemokines to macrophages and neutrophils in the human inflamed synovium. Arthritis Res (2002) 0.80
The origin of the apparent synovial lining cell hyperplasia in rheumatoid arthritis: evidence for a deep stem cell. Br J Exp Pathol (1987) 0.78
Utility of arthroscopic guided synovial biopsy in understanding synovial tissue pathology in health and disease states. World J Orthop (2014) 0.77
Possible origin of synovial lining cell hyperplasia in rheumatoid arthritis. J R Soc Med (1987) 0.77
Bone marrow contribution to synovial hyperplasia following joint surface injury. Arthritis Res Ther (2016) 0.75
Professor Derek Albert Willoughby (1930-2004). Inflammopharmacology (2005) 0.75
The inflammatory role of phagocyte apoptotic pathways in rheumatic diseases. Nat Rev Rheumatol (2016) 0.75
2nd International meeting on synovium cell biology, physiology and pathology. Canterbury, United Kingdom, 21-23 September 1994. Proceedings and abstracts. Ann Rheum Dis (1995) 0.75
Role of marrow-derived monocytes and mesangial cells in removal of immune complexes from renal glomeruli. J Exp Med (1979) 2.27
The cellular evolution of inflammatory granulomata. J Pathol Bacteriol (1966) 2.26
Giant granules in leukocytes of the beige mouse. J Hered (1968) 2.08
Evidence for the presence of receptors for C3 and IgG Fc on human synovial cells. Arthritis Rheum (1980) 1.54
DNA synthesis in human rheumatoid and nonrheumatoid synovial lining. Ann Rheum Dis (1980) 1.36
The pig synovium, II. Some properties of isolated intimal cells. J Anat (1977) 1.35
Mononuclear cells in human synovial fluid. Identification of lymphoblasts in rheumatoid arthritis. Arthritis Rheum (1976) 1.34
Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine. J Pathol (1971) 6.97
Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med (1999) 6.91
Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther (1981) 6.71
The formation of a structure with the features of synovial lining by subcutaneous injection of air: an in vivo tissue culture system. J Pathol (1981) 3.99
Central and peripheral effects of anti-lymphocyte sera. Lancet (1967) 3.76
Possible new role for NF-kappaB in the resolution of inflammation. Nat Med (2001) 3.53
Apatite deposition disease. A new arthropathy. Lancet (1976) 3.53
The origin of the mononuclear cells in inflammatory exudates induced by fibrinogen. J Pathol Bacteriol (1965) 3.34
Screens for anti-inflammatory drugs. J Pharm Pharmacol (1971) 3.24
Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci U S A (1994) 3.20
Heme oxygenase: a novel target for the modulation of the inflammatory response. Nat Med (1996) 3.12
Immunostimulant therapy with levamisole for rheumatoid arthritis. Lancet (1976) 3.07
The codependence of angiogenesis and chronic inflammation. FASEB J (1997) 3.02
Complement in acute inflammation. J Pathol (1969) 2.20
Cardiac surgery in Wessex: review of 1000 consecutive open-heart procedures. Br Med J (1976) 2.16
A histopathological and pharmacological analysis of the mode of action of nonsteroidal anti-inflammatory drugs. J Pathol (1971) 2.15
Treatment of multiple-hormone-producing malignant islet-cell tumour with streptozotocin. Lancet (1968) 2.14
Remission of inflammatory arthropathy in association with anti-CD20 therapy for non-Hodgkin's lymphoma. Rheumatology (Oxford) (1999) 2.14
An analysis of the effects of some types of anti-lymphocyte sera on contact hypersensitivity and certain models of inflammation. Immunology (1968) 2.07
Detection of antigen-antibody binding events with the atomic force microscope. Biochemistry (1997) 2.05
Increased inflammatory reactivity in newly formed lining tissue. J Pathol (1983) 2.01
B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients. Rheumatology (Oxford) (2005) 1.83
Temporal and spatial immunolocalization of cytokines in murine chronic granulomatous tissue. Implications for their role in tissue development and repair processes. Lab Invest (1993) 1.80
Synovial fluid crystals. Q J Med (1979) 1.77
Effect of endothelin-1 on croton oil-induced granulation tissue in the rat. A pharmacologic and immunohistochemical study. Lab Invest (1992) 1.69
B cell depletion therapy in systemic lupus erythematosus: effect on autoantibody and antimicrobial antibody profiles. Arthritis Rheum (2006) 1.65
Light microscopic characterization of the fibroblast-like synovial intimal cell (synoviocyte). Arthritis Rheum (1992) 1.60
Characterization of a yeast mitochondrial promoter by deletion mutagenesis. Proc Natl Acad Sci U S A (1985) 1.59
Macrophage proliferation in vitro induced by exudates. Nature (1975) 1.55
The identification of particulate matter in biological tissues and fluids. J Pathol (1977) 1.54
Analysis of transcriptional initiation of yeast mitochondrial DNA in a homologous in vitro transcription system. Cell (1982) 1.53
Expression of vascular cell adhesion molecule-1 in normal and inflamed synovium. Lab Invest (1993) 1.50
Clinical outcome after one year following samarium-153 particulate hydroxyapatite radiation synovectomy. Scand J Rheumatol (1996) 1.50
Diagnostic categories in rheumatology. Ann Rheum Dis (1987) 1.49
The origin of mononuclear cells in chronic inflammation and tuberculin reactions in the rat. J Pathol Bacteriol (1968) 1.47
Controlled prospective study of the effect on liver function of multiple exposures to halothane. Lancet (1975) 1.46
Distribution of prostaglandins in inflammatory exudate. J Pathol (1973) 1.45
Possible pharmacological mediators of delayed hypersensitivity. Br Med Bull (1967) 1.43
Lymph node permeability factor in the dinitrochlorobenzene skin hypersensitivity reaction in guinea-pigs. Immunology (1965) 1.42
Identification of a single transcriptional initiation site for the glutamic tRNA and COB genes in yeast mitochondria. Proc Natl Acad Sci U S A (1983) 1.42
An investigation into the possible involvement of platelet activating factor in experimental allergic encephalomyelitis in rats. Agents Actions (1989) 1.42
Direct degradation of articular cartilage by rheumatoid synovial fluid: contribution of proteolytic enzymes. J Rheumatol (1994) 1.41
Where is the evidence? CMAJ (1993) 1.40
Evidence for an endogenous antigen in the adjuvant arthritic rat. J Pathol (1973) 1.40
Cyclo-oxygenase and nitric oxide synthase isoforms in rat carrageenin-induced pleurisy. Br J Pharmacol (1994) 1.40
A comparison of the performance of two types of infusion device. Anaesthesia (1992) 1.39
Initiation of transcription of the yeast mitochondrial gene coding for ATPase subunit 9. Nucleic Acids Res (1983) 1.39
A clinical and echocardiographic study of patients with the hypermobility syndrome. Ann Rheum Dis (1981) 1.39
Mixed crystal deposition disease and osteoarthritis. Br Med J (1978) 1.39
Pertussis vaccine pleurisy: a model of delayed hypersensitivity. Agents Actions (1976) 1.37
Possible involvement of S-nitrosothiols in the activation of guanylate cyclase by nitroso compounds. FEBS Lett (1980) 1.36
Induction of tumor necrosis factor alpha production by adhered human monocytes: a key role for Fcgamma receptor type IIIa in rheumatoid arthritis. Arthritis Rheum (2000) 1.34
Atypical prion protein in sheep brain collected during the British scrapie-surveillance programme. J Gen Virol (2006) 1.32
A quantitative study of leucocyte emigration in chronic inflammatory granulomata. J Pathol Bacteriol (1967) 1.32
An induced extracellular matrix protein reverses the polarity of band 3 in intercalated epithelial cells. Cell (1994) 1.31
Quantitative studies on cell-mediated immunity in the pleural cavity of guinea-pigs. J Pathol (1975) 1.30
A comparative study of the cellular, exudative and histological responses to carrageenan, dextran and zymosan in the mouse. Int J Tissue React (1991) 1.25
Long-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPD. Eur Respir J (2004) 1.25
Mediators of the inflammatory response and their modification by therapeutic agents. Proc R Soc Med (1967) 1.25
Relaxation of intrapulmonary artery and vein by nitrogen oxide-containing vasodilators and cyclic GMP. J Pharmacol Exp Ther (1984) 1.23
Hyaluronan concentration in non-inflamed and rheumatoid synovium. Br J Rheumatol (1994) 1.22
Fatty acids and the release of glucagon from isolated guinea-pig islets of Langerhans incubated in vitro. Biochim Biophys Acta (1970) 1.20
Leukocytes: their role in the etiopathogenesis of skin damage in venous disease. J Vasc Surg (1993) 1.19
Studies on delayed hypersensitivity pleural exudates in guinea pigs. I. Demonstration of substances in the cell-free exudate which cause inhibition of mononuclear cell migration in vitro. Immunology (1976) 1.19
The interrelations of complement and a prostaglandin-like substance in acute inflammation. J Pathol (1970) 1.18
Calcium pyrophosphate-induced pleurisy in rats: a new model of acute inflammation. Agents Actions (1975) 1.18
Pertussis vaccine oedema: an experimental model for the action of penicillamine-like drugs. Agents Actions (1976) 1.17
Further studies on carrageenan-induced pleurisy in rats. J Pathol (1975) 1.17
The pharmacological modulation of angiogenesis in chronic granulomatous inflammation. J Pharmacol Exp Ther (1995) 1.16
Effects of prostaglandins PGF2a and PGE1 on vascular permeability. J Pathol Bacteriol (1968) 1.15
The apical Cl/HCO3 exchanger of beta intercalated cells. J Biol Chem (1993) 1.14
Repeated B cell depletion in treatment of refractory systemic lupus erythematosus. Ann Rheum Dis (2005) 1.14
T gamma delta cells and their subsets in blood and synovial tissue from rheumatoid arthritis patients. Scand J Immunol (1990) 1.13
Heberden Oration, 1974. Human arthritis applied to animal models. Towards a better therapy. Ann Rheum Dis (1975) 1.13
Clinical skills acquired during third-year surgical clerkships. Am J Surg (1993) 1.13
Inhibition of inducible nitric oxide synthase by peroxisome proliferator-activated receptor agonists: correlation with induction of heme oxygenase 1. J Immunol (1998) 1.12
Mast cells in newly formed lining tissue during acute inflammation: a six day air pouch model in the mouse. Ann Rheum Dis (1986) 1.12
Uridine diphosphoglucose dehydrogenase activity in normal and rheumatoid synovium: the description of a specialized synovial lining cell. Int J Exp Pathol (1993) 1.12
Some scanning electron-microscope observations on stimulated lymphocytes. J Pathol (1971) 1.12
CLIC-1 functions as a chloride channel when expressed and purified from bacteria. J Biol Chem (2000) 1.12
The prevalence and distribution of macrophages bearing Fc gamma R I, Fc gamma R II, and Fc gamma R III in synovium. Scand J Rheumatol (1990) 1.11
Up-regulation and differential expression of the hyaluronan-binding protein TSG-6 in cartilage and synovium in rheumatoid arthritis and osteoarthritis. Osteoarthritis Cartilage (2001) 1.10
Samarium-153-particulate hydroxyapatite radiation synovectomy: biodistribution data for chronic knee synovitis. J Nucl Med (1995) 1.10
Studies into the influence of carrageenan-induced inflammation on articular cartilage degradation using implantation into air pouches. Br J Exp Pathol (1985) 1.10
Differential effects of inhibition of isoforms of cyclooxygenase (COX-1, COX-2) in chronic inflammation. Inflamm Res (1998) 1.09
Connective tissue abnormalities in MRL/1 mice. Ann Rheum Dis (1986) 1.08
Joint physiology: relevant to the rheumatologist? Br J Rheumatol (1998) 1.08
The role of polymorphonuclear leucocytes in acute inflammation in agranulocytic rats. J Pathol (1969) 1.08
Biosynthesis of glucagon in isolated pancreatic islets of guinea pigs. Biochem J (1974) 1.08
The use of the air pouch to study experimental synovitis and cartilage breakdown. Biomed Pharmacother (1986) 1.07
Studies on the mechanism of cartilage degradation. J Pathol (1984) 1.07
Fatty acids as regulators of glucagon secretion. Nature (1969) 1.07
Differential distribution of Fc gamma RIIIa in normal human tissues and co-localization with DAF and fibrillin-1: implications for immunological microenvironments. Immunology (1998) 1.07
Membrane properties and esterase activity of synovial lining cells: further evidence for a mononuclear phagocyte subpopulation. Ann Rheum Dis (1982) 1.06
A highly porous 3-dimensional polyphosphazene polymer matrix for skeletal tissue regeneration. J Biomed Mater Res (1996) 1.06